Tarceva is a medicine used to treat advanced non-small cell lung cancer (NSCLC) that is located in the lung or that has spread throughout the body (metastatic) but has not progressed after four cycles of chemotherapy.
Tarceva is also used to treat NSCLC that is located in the lung or spread throughout the body if you have not responded to other types of chemotherapy.
Additionally, Tarceva is used in combination with gemcitabine to treat advanced pancreatic cancer that cannot be treated surgically or that has spread throughout the body.
Tarceva can cause interstitial lung disease (ILD). ILD is a group of lung diseases affecting the tissue and space around the air sacs of your lungs. ILD is a serious and life-threatening condition. Tell your doctor right away if you experience shortness of breath, cough, or a fever.
Tarceva can cause significant kidney or liver problems. Your doctor will perform periodic blood tests to monitor your kidney and liver function while you are taking Tarceva. It is important to tell your doctor if you have a history of kidney or liver problems.
You can develop a gastrointestinal perforation (a hole in the stomach or intestine) while you are taking Tarceva. Tell your doctor right away if you develop serious or ongoing diarrhea, nausea, loss of appetite, or vomiting.
Tarceva can cause a serious skin disorder. Contact your doctor immediately if you develop a new or worsening skin rash.
Tarceva can cause serious eye disorders. Contact your doctor if you experience any eye pain or vision problems.
Smoking may affect how well Tarceva works for you. If you smoke, you should stop smoking before starting treatment with Tarceva. If you continue to smoke, you should talk to your doctor before taking Tarceva.
Tarceva can cause harm to your unborn baby if you use it during pregnancy. Make sure to use adequate contraception to prevent pregnancy while on therapy with Tarceva and continue to use adequate contraception for at least two weeks after discontinuing Tarceva.